Centiva Capital, LP Seagen Inc. Call Options Transaction History

Centiva Capital, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $18.7 Million - $20.5 Million	99,400 New	99,400 $19.1 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $1.07 Million - $1.27 Million	-7,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $1.01 Million - $1.21 Million	7,500 New	7,500 $1.18 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.